Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06271707 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Stellate Ganglion Block

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 8 months later Apr 15, 2027 → Dec 30, 2028
See other at-risk trials from University of Minnesota

Record History

  1. Primary completion pushed from Apr 15, 2027 to Dec 30, 2028
    • Study completion pushed from Jul 15, 2027 to Dec 30, 2028
    v12
  2. Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Start date changed from estimate of Aug 15, 2025 to May 19, 2025
    v11
  3. Start date: Jun 1, 2025 to Aug 15, 2025v10
  4. Start date: May 15, 2025 to Jun 1, 2025v9
  5. Start date: Apr 1, 2025 to May 15, 2025
    • Primary completion date: Mar 1, 2027 to Apr 15, 2027
    • Study completion date: Jun 1, 2027 to Jul 15, 2027
    v8
Show 6 earlier versionsHide 6 earlier versions
  1. Start date: Feb 1, 2025 to Apr 1, 2025
    • Primary completion date: Jan 1, 2027 to Mar 1, 2027
    • Study completion date: Apr 1, 2027 to Jun 1, 2027
    v7
  2. Start date: Dec 15, 2024 to Feb 1, 2025
    • Primary completion date: Nov 15, 2026 to Jan 1, 2027
    • Study completion date: Feb 15, 2027 to Apr 1, 2027
    v6
  3. Start date: Oct 1, 2024 to Dec 15, 2024
    • Primary completion date: Sep 30, 2026 to Nov 15, 2026
    • Study completion date: Dec 30, 2026 to Feb 15, 2027
    v5
  4. Start date: Sep 1, 2024 to Oct 1, 2024
    • Primary completion date: Aug 30, 2026 to Sep 30, 2026
    • Study completion date: Nov 30, 2026 to Dec 30, 2026
    v4
  5. Start date: Jul 1, 2024 to Sep 1, 2024
    • Primary completion date: Jun 30, 2026 to Aug 30, 2026
    • Study completion date: Sep 30, 2026 to Nov 30, 2026
    v3
  6. Start date: Apr 1, 2024 to Jul 1, 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
Trial Details
NCT Number NCT06271707
Lead Sponsor University of Minnesota
Conditions
(from sponsor)		 Esophagectomy, Pneumonectomy, Lobectomy
Enrollment 48 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov